Evidence map›Paper›PMID 42332781›Full record

ReviewMalaria journal2026

Beyond elimination; addressing challenges in maintaining the malaria elimination status in Suriname.

Stephen Vreden, Hedley Cairo, Gabriela Sanches, Anfernee Neus, Malti Adhin, Marthelise Eersel

Abstract readReview
In one paragraph

Review in Malaria journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Stephen VredenMalaria Elimination Task Force, Paramaribo, Suriname. stephenvreden@yahoo.com.ORCID https://orcid.org/0000-0003-3959-737X
Hedley CairoMalaria Program of the Ministry of Health in Suriname, Paramaribo, Suriname.
Gabriela SanchesMalaria Program of the Ministry of Health in Suriname, Paramaribo, Suriname.
Anfernee NeusMalaria Program of the Ministry of Health in Suriname, Paramaribo, Suriname.
Malti AdhinMalaria Elimination Task Force, Paramaribo, Suriname.
Marthelise EerselMalaria Elimination Task Force, Paramaribo, Suriname.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSuriname has been certified malaria-free by WHO on June 30th 2025. In the post-elimination era, malaria is still requiring full attention of the public health system. This is in particular due to the malaria burden in neighbouring countries and the intense migration across borders related to small scale artisanal gold mining, which poses a risk for re-establishment of malaria into the country. ANALYSIS: Throughout the process of achieving certification of malaria elimination, the National Malaria Program implemented a range of strategies to maintain the zero transmission status. This manuscript describes and explains these strategies, highlighting the recent addition of individual targeted drug administration and presumptive antimalarial treatment. In the context of maintaining the elimination status of Suriname, the regional malaria situation is presented and the importance of a regional strategy in the ongoing fight against malaria addressed.

conclusionSuriname is extremely susceptible for re-establishment of malaria. The National Malaria Elimination Task Force implemented innovative strategies, adapted to the dynamics of malaria importation. Next to these national actions, it is pivotal that the malaria situation in the Guiana Shield is addressed with a regional effort.

Indexed as

AntimalarialsDisease EradicationMalariaHumansSurinameAntimalarialsEliminationInnovationMalariaRe-establishment

Identifiers

PMID42332781
PMCPMC13548703

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.